About Cullinan Therapeutics
Cullinan Therapeutics is a clinical-stage biopharmaceutical company dedicated to accelerating potential first- or best-in-class, high-impact therapies for people living with autoimmune diseases and cancer. Founded in 2016, the company has evolved from its oncology roots into a hybrid player with a robust pipeline spanning both autoimmune and cancer indications. Cullinan's diversified portfolio includes clinical-stage assets like CLN-978 for systemic lupus erythematosus and rheumatoid arthritis, CLN-049 for acute myeloid leukemia, and zipalertinib (CLN-081/TAS6417) for EGFR exon 20 insertion NSCLC. The company's approach leverages deep expertise in immune modulation and T cell engagers, established in oncology and now advancing into autoimmune diseases.
With headquarters in Cambridge, Massachusetts, and a workforce of approximately 109 employees, Cullinan operates at the intersection of speed and strategy - deliberately advancing only the most promising molecules to address high unmet medical needs. The company's pipeline reflects a rigorous scientific approach with multiple programs in clinical development, including recent FDA clearance for CLN-978 in lupus and positive Phase 2b data for zipalertinib. Cullinan's mission-driven culture focuses on improving patients' lives by developing therapies that allow people to spend less time managing their conditions and more time on what matters most.
FAQs
- When was Cullinan Therapeutics founded?
- Cullinan Therapeutics was founded in 2016.
- Who is the CEO of Cullinan Therapeutics?
- Nadim Ahmed is the CEO.
- What industries or markets does Cullinan Therapeutics operate in?
- Cullinan Therapeutics operates in the following markets: Biotechnology, Pharmaceutical Research & Development, Clinical Stage Drug Development, Oncology Therapeutics, Autoimmune Disease Therapeutics, Immunology & Immune Modulation, Targeted Cancer Therapies (Precision Medicine), Small Molecule Drug Development, T Cell Engagers & Antibody Based Therapeutics, and Biopharmaceutical.
- How many employees does Cullinan Therapeutics have?
- Cullinan Therapeutics has 51-200 employees.
- Where does Cullinan Therapeutics have employees?
- Cullinan Therapeutics has employees in United States.
- Is Cullinan Therapeutics hiring?
- Yes, Cullinan Therapeutics has 2 open remote jobs.
- Does Cullinan Therapeutics support remote work or working from home?
- Yes, Cullinan Therapeutics is a remote-friendly company.
- What employee benefits does Cullinan Therapeutics offer?
- Cullinan Therapeutics provides 4 benefits to their employees.
- Does Cullinan Therapeutics offer a four-day work week?
- No, Cullinan Therapeutics does not offer a four-day work week.
- Is Cullinan Therapeutics transparent about salaries?
- Yes, Cullinan Therapeutics practices salary transparency, often including salary or compensation ranges in their job posts. They provide salary data for 2 roles.
- What is Cullinan Therapeutics's website?
- Cullinan Therapeutics's website is cullinantherapeutics.com.
United States